237 related articles for article (PubMed ID: 24755648)
1. The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.
Laggai S; Kessler SM; Boettcher S; Lebrun V; Gemperlein K; Lederer E; Leclercq IA; Mueller R; Hartmann RW; Haybaeck J; Kiemer AK
J Lipid Res; 2014 Jun; 55(6):1087-97. PubMed ID: 24755648
[TBL] [Abstract][Full Text] [Related]
2. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
3. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance.
Moon YA; Ochoa CR; Mitsche MA; Hammer RE; Horton JD
J Lipid Res; 2014 Dec; 55(12):2597-605. PubMed ID: 25281760
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.
Tybl E; Shi FD; Kessler SM; Tierling S; Walter J; Bohle RM; Wieland S; Zhang J; Tan EM; Kiemer AK
J Hepatol; 2011 May; 54(5):994-1001. PubMed ID: 21145819
[TBL] [Abstract][Full Text] [Related]
5. Elovl6 promotes nonalcoholic steatohepatitis.
Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H
Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid elongase 6 plays a role in the synthesis of long-chain fatty acids in goat mammary epithelial cells.
Shi HB; Wu M; Zhu JJ; Zhang CH; Yao DW; Luo J; Loor JJ
J Dairy Sci; 2017 Jun; 100(6):4987-4995. PubMed ID: 28390727
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
[TBL] [Abstract][Full Text] [Related]
8. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.
Kessler SM; Pokorny J; Zimmer V; Laggai S; Lammert F; Bohle RM; Kiemer AK
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G328-36. PubMed ID: 23257922
[TBL] [Abstract][Full Text] [Related]
9. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.
Moon YA; Hammer RE; Horton JD
J Lipid Res; 2009 Mar; 50(3):412-423. PubMed ID: 18838740
[TBL] [Abstract][Full Text] [Related]
10. Tissue expression profiles and transcriptional regulation of elongase of very long chain fatty acid 6 in bovine mammary epithelial cells.
Chen S; He H; Liu X
PLoS One; 2017; 12(4):e0175777. PubMed ID: 28414811
[TBL] [Abstract][Full Text] [Related]
11. Elovl6: a new player in fatty acid metabolism and insulin sensitivity.
Matsuzaka T; Shimano H
J Mol Med (Berl); 2009 Apr; 87(4):379-84. PubMed ID: 19259639
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SREBP1 (sterol regulatory element binding protein 1) promotes de novo fatty acid synthesis and triacylglycerol accumulation in goat mammary epithelial cells.
Xu HF; Luo J; Zhao WS; Yang YC; Tian HB; Shi HB; Bionaz M
J Dairy Sci; 2016 Jan; 99(1):783-95. PubMed ID: 26601584
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
Kessler SM; Simon Y; Gemperlein K; Gianmoena K; Cadenas C; Zimmer V; Pokorny J; Barghash A; Helms V; van Rooijen N; Bohle RM; Lammert F; Hengstler JG; Mueller R; Haybaeck J; Kiemer AK
Int J Mol Sci; 2014 Apr; 15(4):5762-73. PubMed ID: 24714086
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
16. The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance.
Sun H; Jiang T; Wang S; He B; Zhang Y; Piao D; Yu C; Wu N; Han P
Diabetes Res Clin Pract; 2013 Dec; 102(3):183-92. PubMed ID: 24262945
[TBL] [Abstract][Full Text] [Related]
17. The roles of
Li X; Lyu C; Luo Z; Zhao J; Wang Z; Yang C; Dai Q; Li H; Zhou Y; Li Z; Chen F; Gao Y
Food Funct; 2021 Oct; 12(20):10253-10262. PubMed ID: 34549217
[No Abstract] [Full Text] [Related]
18. Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation.
Dembek A; Laggai S; Kessler SM; Czepukojc B; Simon Y; Kiemer AK; Hoppstädter J
Immunobiology; 2017 Jun; 222(6):786-796. PubMed ID: 28132721
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Elovl6 gene expression is regulated by the synergistic action of ChREBP and SREBP-1c.
Bae JS; Oh AR; Lee HJ; Ahn YH; Cha JY
Biochem Biophys Res Commun; 2016 Sep; 478(3):1060-6. PubMed ID: 27524233
[TBL] [Abstract][Full Text] [Related]
20. ELOVL6 promoter binding sites directly targeted by sterol regulatory element binding protein 1 in fatty acid synthesis of goat mammary epithelial cells.
He Q; Luo J; Wu J; Li Z; Yao W; Zang S; Niu H
J Dairy Sci; 2021 May; 104(5):6253-6266. PubMed ID: 33685712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
